Alan Warbritton

2.4k citations
47 papers · 1.9k indexed · h-index 22

Alan Warbritton

47 papers receiving 1.8k citations

Peers

Alan Warbritton
Comparison fields: 5 of 120
  • Pharmacology 479
  • Hepatology 292
  • Cancer Research 224
  • Health, Toxicology and Mutagenesis 198
  • Plant Science 467
Replace Christophe Chesné with:
Christophe Chesné France
Graham R. Betton United Kingdom
Yuan‐Yen Chang Taiwan
William H. Tolleson United States
Harry M. Olson United States
Yanan Tian United States
Sanjay Chanda United States
Yunhuan Liu China
William F. Salminen United States
Caroline Aninat France
Alan Warbritton relative to Christophe Chesné France Christophe Chesné's profile →
Citations per field
00.5×3.0×
Christophe Chesné · 1×
Citations per year

Countries citing papers authored by Alan Warbritton

Since Specialization
Citations

This map shows the geographic impact of Alan Warbritton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Warbritton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Warbritton more than expected).

Fields of papers citing papers by Alan Warbritton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Warbritton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Warbritton. The network helps show where Alan Warbritton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan Warbritton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan Warbritton Line = papers co-authored together Alan Warbritton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201052
2 200911
3 200846
4 2007114
5 200665
6 200619
7 200516
8 200515
9 200411
10 200310
11 200388
12 200114
13 200166
14 2001175
15 200128
16 200174
17 2001218
18 20003
19 199817
20 199416

About Alan Warbritton

Alan Warbritton is a scholar working on Pharmacology, Aging and Hepatology, having authored 47 papers that have together received 1.9k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (13 papers), Carcinogens and Genotoxicity Assessment (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Mycotoxins in Agriculture and Food (4 papers), Contact Dermatitis and Allergies (3 papers), Calpain Protease Function and Regulation (3 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Pharmacology (479 citations), Hepatology (292 citations) and Cancer Research (224 citations). Alan Warbritton has collaborated with scholars based in United States and Canada. Frequent co-authors include Thomas J. Bucci, Paul C. Howard, Harihara M. Mehendale, John R. Latendresse, Ronald J. Lorentzen, Kenneth A. Voss, Michael E Stack, Robert M. Eppley, Dean W. Roberts and Neil R. Pumford. Their work appears in journals such as Toxicology and Applied Pharmacology, Environmental Health Perspectives, Toxicological Sciences, Toxicology and Toxicology and Industrial Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026